...facilities

In May 2004 a new facility for the manufacture, storage and distribution of investigational medicinal products and clinical trial supplies was fully commissioned.

The new facility is designed and constructed to ensure compliance with the Clinical Trial Directive 2001/20EC and other regulations. The facility provides:

35000 square feet dedicated to investigational medicinal products
Specially designed classified clean rooms for phase 1-4 manufacture, primary and secondary packaging
Monitored temperature controlled storage
Purpose-built label production room and systems

This allows us to:

Better meet the needs of our customers through a state of the art operational environment
Consolidate our existing operations into one facility
Increase our capacity
Launch new services to benefit our clients
Ensure that investigational products are produced, stored and distributed in accordance with the requirements of the Clinical Trial Directive 2001/20